Text Size
2 studies found for:    15613699 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Study of Bortezomib Combined With ACVBP in Peripheral T-Cell Lymphoma
Condition: Peripheral T-Cell Lymphoma
Intervention: Drug: Velcade + ACVBP regimen
2 Terminated A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma
Condition: Follicular Lymphoma
Intervention: Drug: Bortezomib
To Top

† Indicates status has not been verified in more than two years